Validation of prognostic scores for survival in cancer patients beyond first-line therapy

BACKGROUND: We aimed to validate prognostic scores for survival in patients undergoing chemotherapy for advanced or metastatic cancer after first-line treatment. METHODS: We previously described two models with good prognostic value based on a combination of Performance Status (PS) and either lactat...

Descripción completa

Detalles Bibliográficos
Autores principales: Trédan, Olivier, Ray-Coquard, Isabelle, Chvetzoff, Gisèle, Rebattu, Paul, Bajard, Agathe, Chabaud, Sylvie, Pérol, David, Saba, Chadi, Quiblier, Florent, Blay, Jean-Yves, Bachelot, Thomas
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063819/
https://www.ncbi.nlm.nih.gov/pubmed/21406082
http://dx.doi.org/10.1186/1471-2407-11-95

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063819/
https://www.ncbi.nlm.nih.gov/pubmed/21406082
http://dx.doi.org/10.1186/1471-2407-11-95

Ejemplares similares